MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Mechanism of action"

  • 2024 International Congress

    How Botulinum Toxin Transformed the American Food Industry

    D. Riley (Cleveland Heights, USA)

    Objective: To highlight an episode of botulism that altered American food packaging technology Background: Early progress in understanding the behavior of botulinum toxin was marked…
  • 2024 International Congress

    Botulinum Toxin A Usage in Movement Disorder Division: A Retrospective Chart Review

    S. Shaikh, R. Figari Jordan (Charlottesville, USA)

    Objective: To evaluate the cost-effectiveness of Botulinum Toxin A in our movement disorder division. Background: Botulinum Toxin A is an FDA-approved treatment for various medical…
  • 2023 International Congress

    Topical Botulinum-Toxin-like Alternatives: A Systematic Literature Review

    S. Maytharakcheep, O. Phokaewvarangkul, R. Bhidayasiri (bangkok, Thailand)

    Objective: To perform a systematic review exploring the relevant literature on BoNT and BoNT-like substances in topical form and clinical trials focusing on facial muscle…
  • 2023 International Congress

    Individual-specific brain functional connectivity mapping of therapeutic response in task-specific focal dystonia

    E. Gordon, K. Matthews, A. Meyer, S. Norris (St. Louis, USA)

    Objective: Determine therapeutic effects of botulinum toxin on functional connectivity in individuals with task-specific dystonia. Background: Isolated task-specific dystonia occurs during specific activities, but not…
  • 2023 International Congress

    Is a Parkinson’s Sialorrhoea service effective?

    C. Williams, J. Adenwalla, B. Mohamed, C. Marquis, C. Thomas, R. Lewis-Morton (cardiff, United Kingdom)

    Objective: Evaluate the efficacy and tolerance of Botulinum Toxin A (BoNT A) in managing sialorrhoea in People with Parkinsons (PwP)Assess impact on quality of life…
  • 2019 International Congress

    Benefit and Weakness with botulinum toxin: time course and relationship.

    P. Kassavetis, K. Alter, C. Lungu, B. Karp (Bathesda, MD, USA)

    Objective: To compare the timecourse of and relationship between benefit and weakness after botulinum toxin (BoNT) injection. Background: The timecourse of benefit onset and duration…
  • 2019 International Congress

    Botulinum toxin content and activity: Potential implications for duration of efficacy in patients with cervical dystonia

    M. Field, A. Splevins, M. Schans, J. Langenberg, D. Noort, P. Picaut, K. Foster (Rijswijk, Netherlands)

    Objective: To quantify the amount of botulinum neurotoxin-A (BoNT-A) protein in each vial of commercial BoNT-A product and compare light chain activity of 150 kDa…
  • 2019 International Congress

    Differences in botulinum toxin long-term treated and non-treated cervical dystonia patients in somatosensory task-related functional imaging response.

    M. Nevrly, P. Hlustik, P. Hok, M. Kaiserova, P. Otruba, Z. Tudos, P. Kanovsky (Olomouc, Czech Republic)

    Objective: Aim of this study is to compare the response of sensorimotor networks to botulinum toxin (BoNT) therapy in naïve and repeatedly-treated CD patients. Background:…
  • 2019 International Congress

    AbobotulinumtoxinA: evidence for long duration of response

    K. Foster, A. Lysandropoulos, P. Picaut (Abingdon, United Kingdom)

    Objective: To assess clinical treatment intervals and duration of response for abobotulinumtoxinA in the management of pediatric and adult spasticity and assess preclinical data that…
  • 2018 International Congress

    Cervical dystonia – changes in resting state cerebellar connectivity induced by botulinum toxin

    M. Nevrlý, P. Hok, P. Otruba, M. Kaiserová, L. Hvizdošová, Z. Tüdös, P. Hluštík, P. Kaňovský (Olomouc, Czech Republic)

    Objective: The aim of our study was to compare the connectivity between large-scale resting state networks and the cerebellum before and after treatment initiation. Background:…
  • 1
  • 2
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley